Limb Compression Therapy and Chemotherapy‐Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self‐Controlled Study( NEURO ‐ GLOVE Trial)
Limb Compression Therapy und Chemotherapie-induzierte periphere Neuropathie bei Frauen mit gynäkologischen Krebsarten: prospektive selbstkontrollierte Studie (NEURO-GLOVE-Trial)
International Journal of Cancer · 01.11.2026 · 159 (9) · 2300-2313
DOI: 10.1002/ijc.70601 ↗Auf einen Blick
Bei 76 Frauen mit gynäkologischen Krebserkrankungen war eine duale mechanische Kompression während der Paclitaxel-Infusion mit seltenerer moderat bis schwerer CIPN verbunden. Der Effekt zeigte sich bis 6 Monate.
Fragestellung
Verringert duale mechanische Kompression während der Paclitaxel-Infusion die Chemotherapie-induzierte periphere Neuropathie bei Frauen mit gynäkologischen Krebsarten?
Methode
Prospektive intraindividuelle selbstkontrollierte Studie bei Patientinnen mit Carboplatin-Paclitaxel; Kompression der nichtdominanten Hand mit zwei OP-Handschuhen und des ipsilateralen Beins mit Kompressionsstrumpf; kontralaterale Gliedmaßen als Kontrollen.
Ergebnisse
Moderate bis schwere CIPN war in den Kompressionsgliedmaßen seltener als in den Kontrollen: Zyklus 3 35,5 % vs. 53,9 % (p = 0,001), EOT 59,2 % vs. 69,7 % (p = 0,021), 3 Monate 28,9 % vs. 52,6 % (p = 0,015), 6 Monate 20,3 % vs. 33,8 % (p = 0,002).
Schlussfolgerung der Autor:innen
Duale mechanische Kompression war mit geringerer Inzidenz und Persistenz von CIPN assoziiert.
Kernaussagen
- 35,5 % vs. 53,9 % moderat bis schwere CIPN in Zyklus 3
- Signifikante Zeit-Gliedmaßen-Interaktionen für sensible und motorische Domänen
- Niedrige CIPN20-Sensory-Scores in den Kompressionsgliedmaßen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Klinische Studie in der Zeitschrift International Journal of Cancer, online erschienen am 18.06.2026. Verfasst von Kadriye Başkurt und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Etlik City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Genital Neoplasms, Female, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Chemotherapy‐induced peripheral neuropathy (CIPN) is a dose‐limiting toxicity of taxane‐based chemotherapy with limited preventive options. We evaluated whether dual‐site mechanical compression during paclitaxel infusion reduces CIPN in women with gynecologic cancers. In this prospective, intraindividual, self‐controlled study, patients receiving carboplatin–paclitaxel underwent compression of the nondominant hand (two surgical gloves) and ipsilateral lower limb (Class II stocking), while contralateral limbs served as controls. CIPN was assessed using CTCAE v5.0 and EORTC QLQ‐CIPN20 at baseline, Cycle 3, end of treatment (EOT), and 3‐ and 6‐month follow‐up. Among 76 patients (median age, 61 years), moderate‐to‐severe CIPN was observed less frequently in compression limbs than in control limbs at Cycle 3 (35.5% vs. 53.9%; p = 0.001), EOT (59.2% vs. 69.7%; p = 0.021), 3 months (28.9% vs. 52.6%; p = 0.015), and 6 months (20.3% vs. 33.8%; p = 0.002). Repeated‐measures analyzes showed significant time‐by‐limb interactions for sensory ( p = 0.003), lower‐extremity sensory ( p = 0.018), and motor domains ( p = 0.041). Sensory CIPN20 scores were lower in compression limbs in the upper extremities from EOT onward (7.5 vs. 10.2; p < 0.001) and in the lower extremities at 3‐month (8.7 vs. 10.7; p < 0.001) and 6‐month follow‐up (7.0 vs. 10.0; p < 0.001). EORTC QLQ‐CIPN20 sensory scores identified grade ≥ 2 neuropathy with AUC values > 0.92 at all time points. Dual‐site mechanical compression was associated with reduced incidence and persistence of CIPN. As a low‐cost and scalable intervention, this strategy may improve treatment tolerability and survivorship outcomes. Trial Registration: ClinicalTrials.gov identifier: NCT07105553
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Etlik City Hospital, Ankara, Turkey.
- Department of Neurology, Etlik City Hospital, Ankara, Turkey.
- Université Paris-Saclay, Gustave Roussy, Inserm, CESP, Villejuif, France.
- Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
- Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey.
ORCID-Profile: Kadriye Başkurt, Galip Can Uyar, Enes Yeşilbaş, Fatma Zehra Altunç, Damla Erimhan Çevik, İsmet Murat Melek, Yasemin Eren, Ömür Berna Çakmak Öksüzoğlu, Kadriye Bir Yücel, Antonio Di Meglio, Isabelle Ray-Coquard, Osman Sütcüoğlu
Zitieren
APA
Başkurt, K., Uyar, G. C., Yeşilbaş, E., Altunç, F. Z., Çevik, D. E., Melek, İ. M., Eren, Y., Öksüzoğlu, Ö. B. Ç., Yücel, K. B., Di Meglio, A., Ray-Coquard, I., & Sütcüoğlu, O. (2026). Limb Compression Therapy and Chemotherapy‐Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self‐Controlled Study( NEURO ‐ GLOVE Trial). International Journal of Cancer, 159(9), 2300-2313. https://doi.org/10.1002/ijc.70601
Vancouver
Başkurt K, Uyar GC, Yeşilbaş E, Altunç FZ, Çevik DE, Melek İM, et al. Limb Compression Therapy and Chemotherapy‐Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self‐Controlled Study( NEURO ‐ GLOVE Trial). International Journal of Cancer. 2026;159(9):2300-2313. doi:10.1002/ijc.70601
BibTeX
@article{Bakurt2026,
author = {Başkurt, Kadriye and Uyar, Galip Can and Yeşilbaş, Enes and Altunç, Fatma Zehra and Çevik, Damla Erimhan and Melek, İsmet Murat and Eren, Yasemin and Öksüzoğlu, Ömür Berna Çakmak and Yücel, Kadriye Bir and Di Meglio, Antonio and Ray-Coquard, Isabelle and Sütcüoğlu, Osman},
title = {Limb Compression Therapy and Chemotherapy‐Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self‐Controlled Study( NEURO ‐ GLOVE Trial)},
journal = {International Journal of Cancer},
year = {2026},
volume = {159},
number = {9},
pages = {2300--2313},
doi = {10.1002/ijc.70601}
}
EUVIMED